Over the past 15 years, outbreaks of Ebola, Middle East respiratory syndrome (MERS), severe acute respiratory syndrome (SARS), and H1N1 have demonstrated the lack of an adequate local and global health system infrastructure to prevent or mitigate the systemic burdens that result from infectious disease incidents of international significance.
A new multinational, independent expert commission has been established to study and recommend what is needed for a more effective global architecture for countering the threat of epidemic infectious diseases. This Commission on Global Health Risk Framework for the Future - for which the U.S. National Academy of Medicine (NAM) is providing organizational and management functions - will have its first public meeting Wednesday, July 29, in Washington, D.C. The meeting will include sessions on the background for and the charge to the Commission; the landscape of related global initiatives; key challenges and lessons learned for preparedness and response to globally significant infectious disease outbreaks; and the role of government, communities, and the private sector in responding to outbreaks of global significance.
Eighteen members from 11 countries comprise the Commission, which is chaired by Peter Sands, former group chief executive officer, Standard Chartered Bank PLC, and senior fellow, Mossavar-Rahmani Center for Business and Government, Harvard Kennedy School of Government. Oyewale Tomori, president, Nigeria Academy of Sciences, is serving as vice-chair. After its initial meeting, the Commission will gather evidence for its report from four workshops held in August and September in different parts of the world. Beyond capturing lessons learned from the recent Ebola and other global outbreaks, workshop topic areas include governance for global health, financing to contain pandemic threats, resilient health systems, and research and development of medical products. The Commission's final report is scheduled to release by the end of 2015.
The NAM and National Academies of Sciences, Engineering, and Medicine's affiliation with the Commission is to provide expertise and project management, including for the workshops and their summaries; the final report with the consensus conclusions and recommendations will be a product of the independent Commission and not of NAM or the Academies.
Impact of glucagon-like peptide-1 receptor agonists on alcohol consumption